Dosimetric consequences of increased seed strength for I-125 prostate implants-Reference-Cited by-同舟云学术

Dosimetric consequences of increased seed strength for I-125 prostate implants

Published:2003-09 Issue:3 Volume:68 Page:295-297
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Sloboda Ron S,Pedersen John E,Hanson John,Halperin Ross M

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference14 articles.

1. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy;Davis;Cancer,1999

2. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland;Desai;Radiat Oncol Investig,1998

3. Lee WR, Lawton C, Gillin M (Study Chairs). A phase II study of external beam radiation therapy combined with permanent source brachytherapy for intermediate risk clinically localized adenocarcinoma of the prostate. Radiation Therapy Oncology Group protocol P-0019; 13 November 2000.

4. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis;Nag;Int J Radiat Oncol Biol Phys,2000

5. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43;Nath;Med Phys,1995

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer;Brachytherapy;2016-09

2. Practical considerations in the selection of seed strength for prostate implants;Journal of Applied Clinical Medical Physics;2015-09

3. Sector analysis provides additional spatial information on the permanent prostate brachytherapy learning curve;Brachytherapy;2015-09

4. Single-nucleotide polymorphisms studied for associations with urinary toxicity from 125I prostate brachytherapy implants;Brachytherapy;2014-05

5. Regional treatment margins for prostate brachytherapy;Brachytherapy;2013-11